First of all, this is different from other moves b
Post# of 148112
Second, the bid is NOT for CYDY, it is for Leronlimab, remember it's for Leronlimab even if CYDY has a low stock price, the product is LL. I would, as I said, like to see a $40 GSK share for two CYDY, i.e., $20 a share to start.